Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2014-06-17 Director's Dealing
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2014-06-17 English
BALCHEM CORPORATION 8-K 6-3-2014
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 3, 2014, reporting the appointment of a new Chief Financial Officer and changes in senior management positions. The key section is Item 5.02, which specifically addresses the departure and appointment of directors or certain officers. There is no financial data or report content, only an announcement of management changes. Therefore, this filing fits the category of Board/Management Information (MANG). The document length is 3012 characters, which is consistent with a brief announcement rather than a full report.
2014-06-04 English
BALCHEM CORPORATION 8-K 5-14-2014
Board/Management Information Classification · 100% confidence The document is a Form 8-K filing dated May 14, 2014, from Balchem Corporation. The key content is the announcement of the departure of a senior officer, Richard A. Bendure, who stepped down as COO. This fits the description of announcements related to changes in the company's board of directors or senior management. The document is short (2143 characters) and does not contain financial data or detailed reports, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement or regulatory filing of a different nature. Therefore, the appropriate classification is Board/Management Information (MANG).
2014-05-20 English
FORM 3
Director's Dealing
2014-05-19 English
FORM 4
Director's Dealing
2014-05-16 English
BALCHEM CORPORATION 8-K 5-7-2014
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 7, 2014, for Balchem Corporation. It details the entry into a material definitive agreement, specifically a Credit Agreement and related loan documents. The content focuses on the terms and conditions of the credit facilities, including loan amounts, interest rates, covenants, and security interests. This is a current report disclosing a significant financing event, not a full financial report or earnings release. The document is not an announcement of a report publication but the actual filing of the credit agreement details. Therefore, it fits the category of Capital/Financing Update (CAP).
2014-05-13 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.